NeoGenomics
NEO
$14.80
Share price
-1.27%
Change (1 day)
-17.27%
Change (1 year)
NeoGenomics (NEO) - P/B ratio
P/B ratio as of May 2024 : 2.05
According to NeoGenomics
's latest financial reports the company has a price-to-book ratio of 2.05.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
NeoGenomics - P/B ratio (from 2001 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 2.19 | 87.32% |
| 2022-12-31 | 1.17 | -69.15% |
| 2021-12-31 | 3.79 | -55.98% |
| 2020-12-31 | 8.61 | 42.54% |
| 2019-12-31 | 6.04 | 62.49% |
| 2018-12-31 | 3.72 | 6.75% |
| 2017-12-31 | 3.48 | -3.42% |
| 2016-12-31 | 3.61 | 43.89% |
| 2015-12-31 | 2.51 | -39.74% |
| 2014-12-31 | 4.16 | -49.22% |
| 2013-12-31 | 8.19 | -32.79% |
| 2012-12-31 | 12.2 | 18.71% |
| 2011-12-31 | 10.3 | -33.86% |
| 2010-12-31 | 15.5 | 57% |
| 2009-12-31 | 9.88 | -23.3% |
| 2008-12-31 | 12.9 | -11.73% |
| 2007-12-31 | 14.6 | -98.04% |
| 2006-12-31 | 745 | -17174.31% |
| 2005-12-31 | -4.36 | -65.45% |
| 2004-12-31 | -12.6 | 403.22% |
| 2003-12-31 | -2.51 | -101.63% |
| 2002-12-31 | 154 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Quest Diagnostics
DGX | 2.45 | 19.67% | 🇺🇸 USA |
 LabCorp LH | 2.23 | 8.75% | 🇺🇸 USA |
 RadNet RDNT | 5.22 | 154.94% | 🇺🇸 USA |
 Psychemedics PMD | 2.24 | 9.68% | 🇺🇸 USA |
 Enzo Biochem ENZ | 0.7889 | -61.46% | 🇺🇸 USA |